Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
levobunolol | adrenergic receptor beta-1 | NA | Successful target | TTD , DGIDB | Glaucoma Open-Angle[MeSHID:D005902] Ocular Hypertension[MeSHID:D009798] Physiologic Intraocular Pressure[MeSHID:D007429] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.31 | approved | antagonist |
levobunolol | adrenergic receptor beta-1 | NA | Successful target | TTD , DGIDB | Glaucoma Open-Angle[MeSHID:D005902] Ocular Hypertension[MeSHID:D009798] Physiologic Intraocular Pressure[MeSHID:D007429] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.31 | approved | unknown |
levobunolol | beta-1 adrenergic receptor | small molecule | NA | drugbank , DGIDB | Glaucoma Open-Angle[MeSHID:D005902] Ocular Hypertension[MeSHID:D009798] Physiologic Intraocular Pressure[MeSHID:D007429] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.31 | approved | antagonist |
levobunolol | beta-2 adrenergic receptor | small molecule | NA | drugbank , DGIDB | Glaucoma Open-Angle[MeSHID:D005902] Ocular Hypertension[MeSHID:D009798] Physiologic Intraocular Pressure[MeSHID:D007429] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.54 | approved | antagonist |
click here to return to the previous page |